Literature DB >> 24291745

Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage.

Hua Li1, Wei Wu1, Qing Sun1, Ming Liu2, Wei Li1, Xiang-sheng Zhang3, Meng-liang Zhou1, Chun-hua Hang4.   

Abstract

Convincing evidence indicates that inflammation contributes to the adverse prognosis of subarachnoid hemorrhage (SAH). Some pro-inflammatory molecules such as high mobility group protein 1, S100 family of proteins, β-amyloid peptide, and macrophage antigen complex 1 have been involved in the damaging inflammation process following SAH. The receptor for advanced glycation end-products (RAGE) is a transmembrane receptor that senses these molecules and plays central role in inflammatory processes. This study aimed to determine the expression and cell distribution of RAGE in the brain cortex after SAH. Male Sprague-Dawley rats were randomly divided into sham group and SAH groups at 6 h, 12 h and on day 1, day 2 and day 3 (n=6 for each subgroup). SAH groups suffered experimental SAH by injection of 0.3 ml autologous blood into the prechiasmatic cistern. RAGE expression was measured by Western blot, real-time PCR, immunohistochemistry and immunofluorescence. Nuclear expression of p65 protein, the major subunit of nuclear factor kappa B, was also detected. Our data demonstrated that the expression levels of RAGE and nuclear p65 protein were both markedly increased after SAH. Moreover, there was a significant positive correlation between the expression of RAGE and that of p65 protein. Double immunofluorescence staining showed that RAGE was expressed by neuron and microglia rather than astrocyte after SAH. These results suggest that RAGE may be directly involved in the inflammatory response after SAH, and there might be important implications for further studies using specific RAGE antagonists to decrease inflammation-mediated brain injury following SAH.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Aβ; CNS; GFAP; HMGB1; Iba1; Inflammation; Mac-1; NF-κB; NeuN; Nuclear factor kappa B; PCR; RAGE; Receptor for advanced glycation end-product; SAH; Subarachnoid hemorrhage; central nervous system; glialfibrillary acidic protein; high mobility group protein 1; ionized calcium binding adaptor molecule 1; macrophage antigen complex 1; neuron specific nuclear protein; nuclear factor kappa B; polymerase chain reaction; receptor for advanced glycation end-products; subarachnoid hemorrhage; β-amyloid peptide

Mesh:

Substances:

Year:  2013        PMID: 24291745     DOI: 10.1016/j.brainres.2013.11.023

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Expression of Cytoplasmic Gelsolin in Rat Brain After Experimental Subarachnoid Hemorrhage.

Authors:  Guang-Bin Xie; Chun-Xi Wang; Chen-Hui Zhou; Hua Li; Xiang-Sheng Zhang; Xiao-Ming Zhou; Li Zhang; Chun-Hua Hang; Meng-Liang Zhou; Ji-Xin Shi
Journal:  Cell Mol Neurobiol       Date:  2015-03-06       Impact factor: 5.046

2.  IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats.

Authors:  Li-Tian Huang; Hua Li; Qing Sun; Ming Liu; Wei-De Li; Song Li; Zhuang Yu; Wu-Ting Wei; Chun-Hua Hang
Journal:  Cell Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.046

Review 3.  Emerging Role of Microglia-Mediated Neuroinflammation in Epilepsy after Subarachnoid Hemorrhage.

Authors:  Jingxue Liang; Jiahong Deng; Xiaolin Liang; Jun Wang; Kewan Wang; Hongxiao Wang; Dadi Qian; Hao Long; Kaijun Yang; Songtao Qi
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

4.  Increased Expression of Caspase-12 After Experimental Subarachnoid Hemorrhage.

Authors:  Hua Li; Jia-Sheng Yu; Hua-Sheng Zhang; Yi-Qing Yang; Li-Tian Huang; Ding-Ding Zhang; Chun-Hua Hang
Journal:  Neurochem Res       Date:  2016-10-07       Impact factor: 3.996

Review 5.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

6.  An imbalance between RAGE/MR/HMGB1 and ATP1α3 is associated with inflammatory changes in rat brain harboring cerebral aneurysms prone to rupture.

Authors:  Eiji Shikata; Takeshi Miyamoto; Tadashi Yamaguchi; Izumi Yamaguchi; Hiroshi Kagusa; Daiki Gotoh; Kenji Shimada; Yoshiteru Tada; Kenji Yagi; Keiko T Kitazato; Yasuhisa Kanematsu; Yasushi Takagi
Journal:  J Neuroinflammation       Date:  2022-06-20       Impact factor: 9.587

7.  Carbonyl stress phenomena during chronic infection with Opisthorchis felineus.

Authors:  Irina V Saltykova; Ludmilla M Ogorodova; Vladimir V Ivanov; Aleksandr O Bogdanov; Elena A Gereng; Ekaterina A Perina; Paul J Brindley; Alexsey E Sazonov
Journal:  Parasitol Int       Date:  2016-01-08       Impact factor: 2.230

8.  Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage.

Authors:  Hua Li; Jia-Sheng Yu; Ding-Ding Zhang; Yi-Qing Yang; Li-Tian Huang; Zhuang Yu; Ru-Dong Chen; Hong-Kuan Yang; Chun-Hua Hang
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

9.  Admission serum high mobility group box 1 (HMGB1) protein predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.

Authors:  Sina Hemmer; Sebastian Senger; Christoph J Griessenauer; Andreas Simgen; Joachim Oertel; Jürgen Geisel; Philipp Hendrix
Journal:  Neurosurg Rev       Date:  2021-07-24       Impact factor: 2.800

10.  Decreased progranulin levels in patients and rats with subarachnoid hemorrhage: a potential role in inhibiting inflammation by suppressing neutrophil recruitment.

Authors:  Chenhui Zhou; Guangbin Xie; Chunxi Wang; Zihuan Zhang; Qiang Chen; Li Zhang; Lingyun Wu; Yongxiang Wei; Hui Ding; Chunhua Hang; Mengliang Zhou; Jixin Shi
Journal:  J Neuroinflammation       Date:  2015-11-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.